Global Miglitol Tablets Market Growth 2024-2030

Publication ID:

LPI11241730

Publication Date:

November 6, 2024

Pages:

111

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Miglitol tablets are a prescription medication used to manage type 2 diabetes mellitus. As an alpha-glucosidase inhibitor, miglitol works by interfering with the digestive enzymes responsible for breaking down carbohydrates in the intestines and it is typically used in combination with other antidiabetic medications to enhance therapeutic outcomes.
The global Miglitol Tablets market size is projected to grow from US$ 118 million in 2024 to US$ 172 million in 2030; it is expected to grow at a CAGR of 6.5% from 2024 to 2030.
The 鈥淢iglitol Tablets Industry Forecast鈥� looks at past sales and reviews total world Miglitol Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Miglitol Tablets sales for 2024 through 2030. With Miglitol Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Miglitol Tablets industry.
This Insight Report provides a comprehensive analysis of the global Miglitol Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Miglitol Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Miglitol Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Miglitol Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Miglitol Tablets.
The development of miglitol tablets has progressed from its initial introduction as a treatment for type 2 diabetes to an integral component of diabetes management strategies. Approved in the 1990s, miglitol was introduced as an alpha-glucosidase inhibitor to address postprandial hyperglycemia. The drug's role in slowing carbohydrate absorption and moderating post-meal blood sugar spikes positioned it as an important option for improving overall glycemic control, particularly when combined with other antidiabetic agents.
In recent years, research has focused on optimizing miglitol's efficacy and understanding its role within the broader context of diabetes management. Studies have explored its effects on long-term glycemic control, weight management, and its potential benefits in reducing the risk of cardiovascular complications associated with diabetes. This ongoing research has helped to clarify its place in treatment regimens and inform best practices for its use, particularly in combination with other medications or lifestyle interventions.
Looking forward, the development trend for miglitol tablets is likely to emphasize personalized treatment approaches and integration with emerging diabetes therapies. Advances in technology and a better understanding of diabetes pathophysiology may lead to more tailored treatment strategies, where miglitol's role is optimized based on individual patient profiles. Additionally, future research might explore its potential benefits in combination with newer classes of diabetes medications or its role in managing diabetes-related complications, further enhancing its therapeutic impact in comprehensive diabetes care.
This report presents a comprehensive overview, market shares, and growth opportunities of Miglitol Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
25mg per Tablet
50mg per Tablet
100mg per Tablet
Segmentation by Application:
Hospital and Clinic
Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
Lunan Pharma
SUN Pharma
Lupin Pharma
Unichem
Healtheon
Glenmark Pharma
Torrent Pharma
Westminster Pharmaceuticals
Towa Pharmaceutical
Shandong New Time Pharmaceutical
Weiao Pharmaceutical (Sichuan)
Zhejiang Medicine
Key Questions Addressed in this Report
What is the 10-year outlook for the global Miglitol Tablets market?
What factors are driving Miglitol Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Miglitol Tablets market opportunities vary by end market size?
How does Miglitol Tablets break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Miglitol Tablets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Miglitol Tablets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Miglitol Tablets by Country/Region, 2019, 2023 & 2030
2.2 Miglitol Tablets Segment by Type
2.2.1 25mg per Tablet
2.2.2 50mg per Tablet
2.2.3 100mg per Tablet
2.3 Miglitol Tablets Sales by Type
2.3.1 Global Miglitol Tablets Sales Market Share by Type (2019-2024)
2.3.2 Global Miglitol Tablets Revenue and Market Share by Type (2019-2024)
2.3.3 Global Miglitol Tablets Sale Price by Type (2019-2024)
2.4 Miglitol Tablets Segment by Application
2.4.1 Hospital and Clinic
2.4.2 Pharmacy
2.4.3 Other
2.5 Miglitol Tablets Sales by Application
2.5.1 Global Miglitol Tablets Sale Market Share by Application (2019-2024)
2.5.2 Global Miglitol Tablets Revenue and Market Share by Application (2019-2024)
2.5.3 Global Miglitol Tablets Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Miglitol Tablets Breakdown Data by Company
3.1.1 Global Miglitol Tablets Annual Sales by Company (2019-2024)
3.1.2 Global Miglitol Tablets Sales Market Share by Company (2019-2024)
3.2 Global Miglitol Tablets Annual Revenue by Company (2019-2024)
3.2.1 Global Miglitol Tablets Revenue by Company (2019-2024)
3.2.2 Global Miglitol Tablets Revenue Market Share by Company (2019-2024)
3.3 Global Miglitol Tablets Sale Price by Company
3.4 Key Manufacturers Miglitol Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Miglitol Tablets Product Location Distribution
3.4.2 Players Miglitol Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Miglitol Tablets by Geographic Region
4.1 World Historic Miglitol Tablets Market Size by Geographic Region (2019-2024)
4.1.1 Global Miglitol Tablets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Miglitol Tablets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Miglitol Tablets Market Size by Country/Region (2019-2024)
4.2.1 Global Miglitol Tablets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Miglitol Tablets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Miglitol Tablets Sales Growth
4.4 APAC Miglitol Tablets Sales Growth
4.5 Europe Miglitol Tablets Sales Growth
4.6 Middle East & Africa Miglitol Tablets Sales Growth
5 Americas
5.1 Americas Miglitol Tablets Sales by Country
5.1.1 Americas Miglitol Tablets Sales by Country (2019-2024)
5.1.2 Americas Miglitol Tablets Revenue by Country (2019-2024)
5.2 Americas Miglitol Tablets Sales by Type (2019-2024)
5.3 Americas Miglitol Tablets Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Miglitol Tablets Sales by Region
6.1.1 APAC Miglitol Tablets Sales by Region (2019-2024)
6.1.2 APAC Miglitol Tablets Revenue by Region (2019-2024)
6.2 APAC Miglitol Tablets Sales by Type (2019-2024)
6.3 APAC Miglitol Tablets Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Miglitol Tablets by Country
7.1.1 Europe Miglitol Tablets Sales by Country (2019-2024)
7.1.2 Europe Miglitol Tablets Revenue by Country (2019-2024)
7.2 Europe Miglitol Tablets Sales by Type (2019-2024)
7.3 Europe Miglitol Tablets Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Miglitol Tablets by Country
8.1.1 Middle East & Africa Miglitol Tablets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Miglitol Tablets Revenue by Country (2019-2024)
8.2 Middle East & Africa Miglitol Tablets Sales by Type (2019-2024)
8.3 Middle East & Africa Miglitol Tablets Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Miglitol Tablets
10.3 Manufacturing Process Analysis of Miglitol Tablets
10.4 Industry Chain Structure of Miglitol Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Miglitol Tablets Distributors
11.3 Miglitol Tablets Customer
12 World Forecast Review for Miglitol Tablets by Geographic Region
12.1 Global Miglitol Tablets Market Size Forecast by Region
12.1.1 Global Miglitol Tablets Forecast by Region (2025-2030)
12.1.2 Global Miglitol Tablets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Miglitol Tablets Forecast by Type (2025-2030)
12.7 Global Miglitol Tablets Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Miglitol Tablets Product Portfolios and Specifications
13.1.3 Pfizer Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Lunan Pharma
13.2.1 Lunan Pharma Company Information
13.2.2 Lunan Pharma Miglitol Tablets Product Portfolios and Specifications
13.2.3 Lunan Pharma Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Lunan Pharma Main Business Overview
13.2.5 Lunan Pharma Latest Developments
13.3 SUN Pharma
13.3.1 SUN Pharma Company Information
13.3.2 SUN Pharma Miglitol Tablets Product Portfolios and Specifications
13.3.3 SUN Pharma Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 SUN Pharma Main Business Overview
13.3.5 SUN Pharma Latest Developments
13.4 Lupin Pharma
13.4.1 Lupin Pharma Company Information
13.4.2 Lupin Pharma Miglitol Tablets Product Portfolios and Specifications
13.4.3 Lupin Pharma Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lupin Pharma Main Business Overview
13.4.5 Lupin Pharma Latest Developments
13.5 Unichem
13.5.1 Unichem Company Information
13.5.2 Unichem Miglitol Tablets Product Portfolios and Specifications
13.5.3 Unichem Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Unichem Main Business Overview
13.5.5 Unichem Latest Developments
13.6 Healtheon
13.6.1 Healtheon Company Information
13.6.2 Healtheon Miglitol Tablets Product Portfolios and Specifications
13.6.3 Healtheon Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Healtheon Main Business Overview
13.6.5 Healtheon Latest Developments
13.7 Glenmark Pharma
13.7.1 Glenmark Pharma Company Information
13.7.2 Glenmark Pharma Miglitol Tablets Product Portfolios and Specifications
13.7.3 Glenmark Pharma Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Glenmark Pharma Main Business Overview
13.7.5 Glenmark Pharma Latest Developments
13.8 Torrent Pharma
13.8.1 Torrent Pharma Company Information
13.8.2 Torrent Pharma Miglitol Tablets Product Portfolios and Specifications
13.8.3 Torrent Pharma Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Torrent Pharma Main Business Overview
13.8.5 Torrent Pharma Latest Developments
13.9 Westminster Pharmaceuticals
13.9.1 Westminster Pharmaceuticals Company Information
13.9.2 Westminster Pharmaceuticals Miglitol Tablets Product Portfolios and Specifications
13.9.3 Westminster Pharmaceuticals Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Westminster Pharmaceuticals Main Business Overview
13.9.5 Westminster Pharmaceuticals Latest Developments
13.10 Towa Pharmaceutical
13.10.1 Towa Pharmaceutical Company Information
13.10.2 Towa Pharmaceutical Miglitol Tablets Product Portfolios and Specifications
13.10.3 Towa Pharmaceutical Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Towa Pharmaceutical Main Business Overview
13.10.5 Towa Pharmaceutical Latest Developments
13.11 Shandong New Time Pharmaceutical
13.11.1 Shandong New Time Pharmaceutical Company Information
13.11.2 Shandong New Time Pharmaceutical Miglitol Tablets Product Portfolios and Specifications
13.11.3 Shandong New Time Pharmaceutical Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shandong New Time Pharmaceutical Main Business Overview
13.11.5 Shandong New Time Pharmaceutical Latest Developments
13.12 Weiao Pharmaceutical (Sichuan)
13.12.1 Weiao Pharmaceutical (Sichuan) Company Information
13.12.2 Weiao Pharmaceutical (Sichuan) Miglitol Tablets Product Portfolios and Specifications
13.12.3 Weiao Pharmaceutical (Sichuan) Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Weiao Pharmaceutical (Sichuan) Main Business Overview
13.12.5 Weiao Pharmaceutical (Sichuan) Latest Developments
13.13 Zhejiang Medicine
13.13.1 Zhejiang Medicine Company Information
13.13.2 Zhejiang Medicine Miglitol Tablets Product Portfolios and Specifications
13.13.3 Zhejiang Medicine Miglitol Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Zhejiang Medicine Main Business Overview
13.13.5 Zhejiang Medicine Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂